Results summary | View all lists in L2L MDB | View all genes in L02B.profile.u50 |
List Name | Description | Total probes |
Expected matches |
Actual matches |
Fold Enrichment |
Binomial p-value |
---|---|---|---|---|---|---|
aom-dss_colon_5wks_up | Up-regulated in mouse colonic mucosa after 5 weeks of treatment with the colon carcinogens azoxymethane (AOM) and 2% dextran sodium sulfate (DSS) vs. untreated controls. | 133 | 0.33 | 4 | 12.17 | 3.61e-04 |
mmc_res_xenografts_up | Up-regulation is correlated with resistance of human cancer xenografts to mitomycin C | 14 | 0.03 | 2 | 57.79 | 5.45e-04 |
dixoin_pbmnc_up | Up-regulated in peripheral blood mononuclear cells of subjects with high exposure to dioxin, compared to low-exposure controls. | 17 | 0.04 | 2 | 47.59 | 8.11e-04 |
cmv_hcmv_timecourse_1hr_dn | Down-regulated in fibroblasts following infection with human cytomegalovirus (at least 3-fold, with Affymetrix change call, in at least two consectutive timepoints), with maximum change at 1 hour | 73 | 0.18 | 3 | 16.62 | 8.25e-04 |
5fu_resist_gastric_dn | Downregulated in gastric cancer cell lines reistant to 5-fluorouracil, compared to parent chemosensitive lines | 30 | 0.07 | 2 | 26.97 | 2.54e-03 |
dex_keratinocyte_4hr_up | Up-regulated in primary human keratinocytes at 4 hours following treatment with 0.1 microM dexamethasone | 35 | 0.09 | 2 | 23.12 | 3.44e-03 |
gh_exogenous_any_dn | Down-regulated at any time point (1-24 hours) following treatment of mammary carcinoma cells (MCF-7) with exogenous human growth hormone | 142 | 0.35 | 3 | 8.55 | 5.46e-03 |
uv-4nqo_fibro_dn | Down-regulated at any timepoint by treatment of human fibroblasts with UV light or 4-NQO, but not by gamma radiation | 48 | 0.12 | 2 | 16.86 | 6.39e-03 |
igf_vs_pdgf_dn | Down-regulated in mouse C2AS12 myoblasts by treatment with IGF1, compared to treatment with PDGF | 53 | 0.13 | 2 | 15.27 | 7.74e-03 |
hdaci_colon_but12hrs_up | Upregulated by butyrate at 12 hrs in SW260 colon carcinoma cells | 54 | 0.13 | 2 | 14.98 | 8.03e-03 |
bap_hepg2_dn | Down-regulated at least 1.4-fold following treatment of HepG2 human hepatocellular carcinoma cells with carcinogen benzo(a)pyrene (BaP), at any time point from 6-48 hours and at any concentration from 0.25-5 microM. | 56 | 0.14 | 2 | 14.45 | 8.61e-03 |